Swedish Orphan Biovitrum AB (publ) (LON:0MTD)
London flag London · Delayed Price · Currency is GBP · Price in SEK
322.81
+4.81 (1.51%)
At close: Dec 17, 2025

LON:0MTD Revenue

Swedish Orphan Biovitrum AB had revenue of 7.78B SEK in the quarter ending September 30, 2025, with 12.79% growth. This brings the company's revenue in the last twelve months to 27.85B, up 9.50% year-over-year. In the year 2024, Swedish Orphan Biovitrum AB had annual revenue of 26.03B with 17.65% growth.

Revenue (ttm)
27.85B SEK
Revenue Growth
+9.50%
P/S Ratio
4.09
Revenue / Employee
15.42M SEK
Employees
1,806
Market Cap
8.99B GBP

Revenue Chart

* This company reports financials in SEK.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202426.03B3.90B17.65%
Dec 31, 202322.12B3.33B17.74%
Dec 31, 202218.79B3.26B21.00%
Dec 31, 202115.53B268.00M1.76%
Dec 31, 202015.26B1.01B7.11%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Shell200.18B
BP p.l.c.138.32B
Unilever51.24B
AstraZeneca43.24B
HSBC Holdings43.13B
Rio Tinto Group39.22B
GSK plc32.17B
Barclays26.02B
Revenue Rankings